BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20077665)

  • 1. [Progress in virus-like particles technique studies].
    Guo JQ; Zhang ZQ
    Zhongguo Yi Miao He Mian Yi; 2009 Apr; 15(2):167-73. PubMed ID: 20077665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-like particles as immunogens.
    Noad R; Roy P
    Trends Microbiol; 2003 Sep; 11(9):438-44. PubMed ID: 13678860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress in development of influenza virus-like particles].
    Ge SQ; Wang ZL
    Bing Du Xue Bao; 2013 Mar; 29(2):224-32. PubMed ID: 23757857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-like particles: potential veterinary vaccine immunogens.
    Liu F; Ge S; Li L; Wu X; Liu Z; Wang Z
    Res Vet Sci; 2012 Oct; 93(2):553-9. PubMed ID: 22100244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
    Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
    Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose.
    Ju H; Wei N; Wang Q; Wang C; Jing Z; Guo L; Liu D; Gao M; Ma B; Wang J
    Biochem Biophys Res Commun; 2011 May; 409(1):131-6. PubMed ID: 21554858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-like particles in vaccine development.
    Roldão A; Mellado MC; Castilho LR; Carrondo MJ; Alves PM
    Expert Rev Vaccines; 2010 Oct; 9(10):1149-76. PubMed ID: 20923267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progess in the development of VLPs vaccine].
    Cao L; Bi SL
    Bing Du Xue Bao; 2011 Jul; 27(4):378-82. PubMed ID: 21874909
    [No Abstract]   [Full Text] [Related]  

  • 9. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins.
    Latham T; Galarza JM
    J Virol; 2001 Jul; 75(13):6154-65. PubMed ID: 11390617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial overview.
    Ertl H; Pulendran B
    Curr Opin Virol; 2011 Oct; 1(4):223-5. PubMed ID: 22440780
    [No Abstract]   [Full Text] [Related]  

  • 11. Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice.
    Li C; Liu F; Liang M; Zhang Q; Wang X; Wang T; Li J; Li D
    Vaccine; 2010 Jun; 28(26):4294-300. PubMed ID: 20433802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric calicivirus-like particles elicit protective anti-viral cytotoxic responses without adjuvant.
    Crisci E; Almanza H; Mena I; Córdoba L; Gómez-Casado E; Castón JR; Fraile L; Bárcena J; Montoya M
    Virology; 2009 May; 387(2):303-12. PubMed ID: 19327809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.
    Swenson DL; Warfield KL; Negley DL; Schmaljohn A; Aman MJ; Bavari S
    Vaccine; 2005 Apr; 23(23):3033-42. PubMed ID: 15811650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillomavirus virus-like particles as vehicles for the delivery of epitopes or genes.
    Xu YF; Zhang YQ; Xu XM; Song GX
    Arch Virol; 2006 Nov; 151(11):2133-48. PubMed ID: 16791442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-like particles as a vaccine delivery system: myths and facts.
    Roy P; Noad R
    Adv Exp Med Biol; 2009; 655():145-58. PubMed ID: 20047040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of novel vaccines based on virus-like particles or chimeric virions.
    Bárcena J; Blanco E
    Subcell Biochem; 2013; 68():631-65. PubMed ID: 23737067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivalent virus-like-particle vaccine protects against classic and variant infectious bursal disease viruses.
    Jackwood DJ
    Avian Dis; 2013 Mar; 57(1):41-50. PubMed ID: 23678728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
    Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-like particles as a vaccine delivery system: myths and facts.
    Roy P; Noad R
    Hum Vaccin; 2008; 4(1):5-12. PubMed ID: 18438104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.